Use of Zebrafish in Drug Discovery Toxicology
Steven Cassar(AbbVie (United States)), Leonard I. Zon(Harvard University Press), Randall T. Peterson(University of Utah), Steven Van Cruchten(University of Antwerp), Iñaki Iturria(Biosensores (Spain)), Joshua T. Gamse(The Bristol-Myers Squibb Children's Hospital), Isaac Adatto, Jennifer L. Freeman(Purdue University West Lafayette), Christian Lawrence(Boston Children's Museum), Arantza Muriana(Policlínica Gipuzkoa)
Cited by 550
Related Papers
Efficient genome editing in zebrafish using a CRISPR-Cas system
|Nature Biotechnology|2013|3k
Engineered CRISPR-Cas9 nucleases with altered PAM specificities
|Nature|2015|1.7k
Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
|Nature|2000|1.7k
In vivo drug discovery in the zebrafish
|Nature Reviews Drug Discovery|2005|1.4k
Vertebrate genome evolution and the zebrafish gene map
|Nature Genetics|1998|837